Macrophagic myofasciitis is characterised by sheets of macrophages in striated muscle, a few lymphocytes and inconspicuous muscle fibre damage. It is due to aluminium contained in vaccines, and is localised to the inoculation site. We report the first Australian case, detected incidentally when investigating a raised serum creatine kinase level.
- 1. Cherin P, Gherardi RK. Emergence of a new entity, macrophagic myofasciitis. Rev Rhum Engl Ed 1998; 65: 541-542.
- 2. Gherardi RK, Authier FJ. Aluminum inclusion macrophagic myofasciitis: a recently identified condition. Immunol Allergy Clin North Am 2003; 23: 699-712.
- 3. Rimaniol AC, Gras G, Verdier F, et al. Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. Vaccine 2004; 22: 3127-3135.
- 4. Gherardi RK, Coquet M, Cherin P, et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001; 124: 1821-1831.
- 5. Nevo Y, Kutai M, Jossiphov J, et al. Childhood macrophagic myofasciitis-consanguinity and clinicopathological features. Neuromuscul Disord 2004; 14: 246-252.
- 6. Gherardi RK, Coquet M, Cherin P, et al. Macrophagic myofasciitis: an emerging entity. Lancet 1998; 352: 347-352.
- 7. Cherin P, Laforet P, Gherardi RK, et al. Macrophagic myofasciitis: description and etiopathogenic hypotheses. Rev Med Interne 1999; 20: 483-489.
- 8. Authier FJ, Cherin P, Creange A, et al. Central nervous system disease in patients with macrophagic myofasciitis. Brain 2001; 124: 974-983.
- 9. Cherin P, Menard D, Mouton P, et al. Macrophagic myofasciitis associated with inclusion body myositis: a report of three cases. Neuromuscul Disord 2001; 11: 452-457.
- 10. Papo T. Macrophagic myofasciitis: focal or systemic? Joint Bone Spine 2003; 70: 242-245.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.